CJ-40001 (darbepoetin alfa biosimilar)
/ Korea Kolmar, YL Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 08, 2018
Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers.
(PubMed, BioDrugs)
- P1; "The test and reference darbepoetin alfa formulations had similar PK, PD, and safety profiles. Thus, it is expected that the two formulations are able to be used interchangeably in clinical settings. ClinicalTrials.gov Identifier: NCT03542916."
Clinical • Journal • PK/PD data
1 to 1
Of
1
Go to page
1